搜索结果 | 泌尿系统常见疾病循证医学证据

证据分类

搜索结果

共搜索到12条与Gemcitabine有关的结果

Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review

 2023 年发布于 Pharmacoeconomics 9 卷第 1 期

Mandrik O. Hahn A. I. Catto J. W. F. Zauber A. G. Cumberbatch M. Chilcott J.

Humans *Gemcitabine Docetaxel/therapeutic use BCG Vaccine/adverse effects Adjuvants Immunologic *Urinary Bladder Neoplasms/therapy Administration Intravesical Neoplasm Invasiveness Neoplasm Recurrence Local
文献简介 原文链接
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis

 2023 年发布于 Eur Urol Focus 47 卷第 4 期

Kawada T. Yanagisawa T. Mostafaei H. Sari Motlagh R. Quhal F. Rajwa P. Laukhtina E. von Deimling M. Bianchi A. Majdoub M. Pallauf M. Pradere B. Teoh J. Y. Karakiewicz P. I. Araki M. Shariat S. F.

Humans Mitomycin Gemcitabine Hematuria *Non-Muscle Invasive Bladder Neoplasms Deoxycytidine/therapeutic use Administration Intravesical *Urinary Bladder Neoplasms/drug therapy *Cystitis Chemical cystitis Cistitis química Cáncer de vejiga sin invasión muscular Gemcitabina intravesical Intravesical gemcitabine Intravesical mitomycin Mitomicina intravesical Non-muscle invasive bladder cancer Recurrence rates Tasas de recurrencia
文献简介 原文链接
Is radiotherapy helpful for the prognosis of upper urinary tract urothelial carcinoma? A meta-analysis

 2022 年发布于 Int J Environ Res Public Health 27 卷第 2 期

Zhou X. Luo G.

Bacillus Calmette-Guérin Chemoablation Epirubicin Gemcitabine Intravesical therapy Mitomycin Non–muscle-invasive bladder cancer
文献简介 原文链接
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria

 2022 年发布于 J Endourol 2022 卷第 4 期

Rai B. P. Luis Dominguez Escrig J. Vale L. Kuusk T. Capoun O. Soukup V. Bruins H. M. Yuan Y. Violette P. D. Santesso N. van Rhijn B. W. G. Hugh Mostafid A. Imran Omar M.

bladder cancer gemcitabine intravesical chemotherapy
文献简介 原文链接
A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral Resection

 2021 年发布于 World J Urol 2 卷第 3 期

Veskimae E. Subbarayan S. Campi R. Carron D. Omar M. I. Yuan C. Dimitropoulos K. Van Hemelrijck M. Bryan R. T. N'Dow J. Babjuk M. Witjes J. A. Sylvester R. MacLennan S.

Adjuvants Immunologic/administration & dosage Administration Intravesical Antibiotics Antineoplastic/administration & dosage/adverse effects Antimetabolites Antineoplastic/*administration & dosage/adverse effects BCG Vaccine/administration & dosage Bias Cause of Death Confidence Intervals Deoxycytidine/administration & dosage/adverse effects/*analogs & derivatives Disease Progression Drug Administration Schedule Humans Mitomycin/administration & dosage/adverse effects Neoplasm Recurrence Local/*drug therapy/mortality/prevention & control Randomized Controlled Trials as Topic Saline Solution/administration & dosage Urinary Bladder Neoplasms/*drug therapy/mortality/pathology/prevention & control Gemcitabine
文献简介 原文链接
Effectiveness of contrast-enhanced ultrasound for detecting the staging and grading of bladder cancer: a systematic review and meta-analysis

 2021 年发布于 World J Urol 39 卷第 6 期

Ge X. Lan Z. K. Chen J. Zhu S. Y.

Administration Intravesical Antibiotics Antineoplastic/*administration & dosage Antimetabolites Antineoplastic/*administration & dosage Deoxycytidine/administration & dosage/*analogs & derivatives Humans Mitomycin/*administration & dosage Neoplasm Invasiveness Randomized Controlled Trials as Topic Urinary Bladder Neoplasms/*drug therapy/pathology Gemcitabine Bladder cancer Meta-analysis Mitomycin Systematic evaluation
文献简介 原文链接
Safety and efficacy of bipolar versus monopolar transurethral resection of bladder tumor: a systematic review and meta-analysis

 2021 年发布于 Prog Urol 151 卷第 6 期

Sharma G. Sharma A. P. Mavuduru R. S. Bora G. S. Devana S. K. Singh S. K. Mandal A. K.

bladder cancer cisplatin dose-dense MVAC gemcitabine neoadjuvant chemotherapy
文献简介 原文链接
CLINICAL SIGNIFICANCE OF 5-alpha REDUCTASE INHIBITOR AND ANDROGEN DEPRIVATION THERAPY IN BLADDER CANCER INCIDENCE, RECURRENCE, AND SURVIVAL: A META-ANALYSIS AND SYSTEMIC REVIEW

 2020 年发布于 Arab J Urol 16 卷第 6 期

Kim A. Kim H. G.

Bacille Calmette-Guérin Nmibc gemcitabine intravesical therapy meta-analysis non-muscle invasive bladder cancer
文献简介 原文链接
Clinical significance of 5-alpha reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review

 2020 年发布于 Prog Urol 41 卷第 6 期

Kim A. Kim M. S. Ahn J. H. Choi W. S. Park H. K. Kim H. G. Paick S. H.

Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Cisplatin/administration & dosage Deoxycytidine/administration & dosage/analogs & derivatives Doxorubicin/administration & dosage Humans Methotrexate/administration & dosage Muscle Neoplasms/*drug therapy/pathology Neoplasm Invasiveness Prognosis Survival Rate Urinary Bladder Neoplasms/*drug therapy/pathology Vinblastine/administration & dosage Gemcitabine Bladder cancer and cisplatin chemotherapy doxorubicin/adriamycin gemcitabine and cisplatin methotrexate vinblastine
文献简介 原文链接
Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs

 2019 年发布于 World J Urol 39 卷第 2 期

Morii Y. Osawa T. Suzuki T. Shinohara N. Harabayashi T. Ishikawa T. Tanikawa T. Yamashina H. Ogasawara K.

Epirubicin/*therapeutic use Female Humans Immunotherapy/*methods Male Mitomycin/*therapeutic use *Mycobacterium bovis Urinary Bladder Neoplasms/immunology/pathology/*therapy Bacillus Calmette–Guérin Consistency Epirubicin Gemcitabine Heterogeneity Interferon-Alpha Intravesical instillation therapies Mitomycin C Pairwise/network meta-analysis Tumor progression Tumor recurrence
文献简介 原文链接
Gemcitabine/cisplatin versus methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive bladder cancer: A systematic review and meta-analysis

 2018 年发布于 Urol Oncol 286 卷第 22 期

Yu C. Hequn C. Jinbo C. Feng Z. Xiongbing Z. Jian D.

Administration Intravesical Aged Aged 80 and over Antineoplastic Combined Chemotherapy Protocols/*administration & dosage/adverse effects BCG Vaccine/administration & dosage Bayes Theorem Deoxycytidine/administration & dosage/analogs & derivatives Disease Progression Epirubicin/administration & dosage Female Humans Isoniazid/administration & dosage Male Middle Aged Mitomycin/administration & dosage Neoplasm Invasiveness Neoplasm Recurrence Local Odds Ratio Randomized Controlled Trials as Topic Risk Factors Time Factors Treatment Outcome Urinary Bladder Neoplasms/*drug therapy/mortality/pathology Gemcitabine efficacy and safety intravesical therapy non-muscle invasive bladder cancer tumor progression tumor recurrence
文献简介 原文链接
Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies

 2018 年发布于 Eur Urol 11 卷第 5 期

Shen P. L. Lin M. E. Hong Y. K. He X. J.

Antineoplastic Combined Chemotherapy Protocols/therapeutic use Bayes Theorem Carcinoma Transitional Cell/*drug therapy/pathology/surgery Cisplatin/therapeutic use Cystectomy Deoxycytidine/analogs & derivatives/therapeutic use Doxorubicin/therapeutic use Humans Methotrexate/therapeutic use *Neoadjuvant Therapy Neoplasm Invasiveness/pathology Urinary Bladder Neoplasms/*drug therapy/pathology/surgery Vinblastine/therapeutic use Gemcitabine
文献简介 原文链接

 2023 年 发布于 Pharmacoeconomics 9 卷 第 1 期

Mandrik O. Hahn A. I. Catto J. W. F. Zauber A. G. Cumberbatch M. Chilcott J.

 2023 年 发布于 Eur Urol Focus 47 卷 第 4 期

Kawada T. Yanagisawa T. Mostafaei H. Sari Motlagh R. Quhal F. Rajwa P. Laukhtina E. von Deimling M. Bianchi A. Majdoub M. Pallauf M. Pradere B. Teoh J. Y. Karakiewicz P. I. Araki M. Shariat S. F.

 2022 年 发布于 Int J Environ Res Public Health 27 卷 第 2 期

Zhou X. Luo G.

 2022 年 发布于 J Endourol 2022 卷 第 4 期

Rai B. P. Luis Dominguez Escrig J. Vale L. Kuusk T. Capoun O. Soukup V. Bruins H. M. Yuan Y. Violette P. D. Santesso N. van Rhijn B. W. G. Hugh Mostafid A. Imran Omar M.

 2021 年 发布于 World J Urol 2 卷 第 3 期

Veskimae E. Subbarayan S. Campi R. Carron D. Omar M. I. Yuan C. Dimitropoulos K. Van Hemelrijck M. Bryan R. T. N'Dow J. Babjuk M. Witjes J. A. Sylvester R. MacLennan S.

 2021 年 发布于 World J Urol 39 卷 第 6 期

Ge X. Lan Z. K. Chen J. Zhu S. Y.

 2021 年 发布于 Prog Urol 151 卷 第 6 期

Sharma G. Sharma A. P. Mavuduru R. S. Bora G. S. Devana S. K. Singh S. K. Mandal A. K.

 2020 年 发布于 Arab J Urol 16 卷 第 6 期

Kim A. Kim H. G.

 2020 年 发布于 Prog Urol 41 卷 第 6 期

Kim A. Kim M. S. Ahn J. H. Choi W. S. Park H. K. Kim H. G. Paick S. H.

 2019 年 发布于 World J Urol 39 卷 第 2 期

Morii Y. Osawa T. Suzuki T. Shinohara N. Harabayashi T. Ishikawa T. Tanikawa T. Yamashina H. Ogasawara K.

 2018 年 发布于 Urol Oncol 286 卷 第 22 期

Yu C. Hequn C. Jinbo C. Feng Z. Xiongbing Z. Jian D.

 2018 年 发布于 Eur Urol 11 卷 第 5 期

Shen P. L. Lin M. E. Hong Y. K. He X. J.

 2023 年发布于 Pharmacoeconomics 9 卷第 1 期

 2023 年发布于 Eur Urol Focus 47 卷第 4 期

 2022 年发布于 Int J Environ Res Public Health 27 卷第 2 期

 2022 年发布于 J Endourol 2022 卷第 4 期

 2021 年发布于 World J Urol 2 卷第 3 期

 2021 年发布于 World J Urol 39 卷第 6 期

 2021 年发布于 Prog Urol 151 卷第 6 期

 2020 年发布于 Arab J Urol 16 卷第 6 期

 2020 年发布于 Prog Urol 41 卷第 6 期

 2019 年发布于 World J Urol 39 卷第 2 期

 2018 年发布于 Urol Oncol 286 卷第 22 期

 2018 年发布于 Eur Urol 11 卷第 5 期